New York, Feb 27, 2026, 11:44 EST — Regular session.
UnitedHealth Group Incorporated (UNH) shares rose on Friday, outpacing a weaker broader market. By 11:44 a.m. EST, the stock was up $4.94, or 1.72%, at $291.60 after trading between $283.85 and $292.78, Investing.com data showed.
The move comes as investors keep tightening U.S. Medicare Advantage rules front and center for managed-care names. Medicare Advantage is the privately run version of Medicare, and small shifts in government payments can ripple into plan pricing, benefits and profit expectations.
UnitedHealth said on Feb. 25 its board authorized a quarterly cash dividend of $2.21 per share, payable March 17 to shareholders of record as of March 9.
Policy risk remains the heavier weight. An analysis of federal data released by consulting firm Chartis found Medicare Advantage enrollment declined in seven states for the 2026 plan year, Axios reported. UnitedHealth’s MA enrollment fell more than 5% from the prior year but it still led the market with nearly 9.3 million enrollees, while Humana gained nearly 1.2 million, according to the report. Alexis Levy, a senior partner at HealthScape Advisors and a co-author of the analysis, said the declines “seem to come from plans exiting the market.” Axios
The enrollment churn is landing as Washington presses on with 2027 payment and risk-scoring changes. The Centers for Medicare & Medicaid Services said its proposed 2027 policies would result in a net average payment increase of 0.09% for Medicare Advantage, and it laid out further updates to “risk adjustment,” the system that boosts payments for sicker patients. CMS Administrator Dr. Mehmet Oz said the proposals are meant to make sure Medicare Advantage “works better for the people it serves.” Centers for Medicare & Medicaid Services
UnitedHealth’s stock has been volatile since late January, when the company warned of a rare annual revenue decline and the Medicare Advantage proposal hit the sector. On Jan. 27, the shares fell as much as 19%; Novare Capital Management’s James Harlow said the proposal “starts to bring in worries about 2027 earnings growth,” while Morningstar analyst Julie Utterback wrote investors hoping for a quick turnaround “may have to wait longer than hoped.” Reuters
For traders, that leaves a familiar setup: the dividend offers a steady cash return, but it does not reduce the policy and medical-cost uncertainty that has driven the tape this year. Any sign the final rate book softens — or tightens — can move estimates fast.
The risk case runs the other way. If the final update stays close to flat and coding rules bite harder than expected, insurers may have to cut benefits, pull back in thin markets or accept lower margins to protect membership.
The next checkpoint is Washington’s final 2027 Medicare Advantage Rate Announcement, due no later than April 6.
